Calcitonin Gene-related Peptide Receptor Completed Phase 1 Trials for Telcagepant (DB12228)

Also known as: Calcitonin Gene-Related Peptide Receptors / Receptors, Calcitonin Gene-Related Peptide

IndicationStatusPhase
DBCOND0050961 (Calcitonin Gene-related Peptide Receptor)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01294709A Study to Assess the Safety, Tolerability, and Effects of MK-0974 (Telcagepant) on Exercise Tolerance in Patients With Stable Angina (MK-0974-014)Treatment